Skip to content

Total at other companies

Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$157.51M
BioLife Solutions logo
BioLife SolutionsBLFS
$88.79M+118%
KDK
Kodiak AI, Inc. Common StockKDK
$25.24M
Absci Corporation logo
Absci CorporationABSI
$122.78M+41.1%
Hagerty logo
HagertyHGTY
$73.56M-21.3%
GitLab logo
GitLabGTLB
$619.16M-1.8%

Other financials

Income statement

See full
Revenue$68.4M+30.1%
Gross profit$49.3M+35.8%
Operating income-$8.1M+37.0%
Net income-$6.3M+44.0%
EPS (diluted)-$0.12+47.8%

Balance sheet

See full
Cash & equivalents$109.3M+37.1%
Total debt$95.0M-4.6%
Total equity$356.2M+20.6%
Total assets$485.6M+14.4%

Cash flow

See full
Operating cash flow$16.4M+148%
CapEx$1.3M-91.2%
Free cash flow$15.1M+299%

Valuation

See full
Market cap$2.19B+3.6%
Enterprise value$2.18B+1.9%
P/E102.1×-608×
P/S7.5×-1.4×

Profitability

See full
Gross margin74.8%+2.3pp
Operating margin5.4%+4.6pp
Net margin7.3%+6.1pp
FCF margin16.3%

Returns & leverage

See full
Return on equity6.6%+5.5pp
Debt / equity0.3×-0.1×
Current ratio5.2×+0.2×

Where this comes from

Reported directly by Vericel in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's total.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vericel's total?
Vericel (VCEL) reported total of $101.5M in Q1 2026.
How has Vericel's total changed year-over-year?
Vericel's total increased by 22.9% year-over-year, from $82.62M to $101.5M.
What is the long-term trend for Vericel's total?
Over 5 years (2020 to 2025), Vericel's total has grown at a 8.3% compound annual growth rate (CAGR), from $66.27M to $98.53M.